Pharmacy

Your Article Summary

See Latest Articles

CTI Focuses on Late-Stage Drug Approvals and Commercialization and Cuts Operating Costs: to Close Bresso Research Center
Cell Therapeutics, 03/02/09

Cell Therapeutics, Inc. announced that it has started a collective dismissal procedure pursuant to Law 223/1991 concerning its Bresso, Italy, employees. The collective dismissal will involve a total of 62 employees. Within 75 days of the consultation procedure, the company, in cooperation with the Trade Unions, will review solutions that may reduce the social impact of the decision.

Today in Drug Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Panel Recommends Approval with Conditions of Medtronic Deep Brain Stimulation Therapy for Patients with Refractory Epilepsy
Medtronic, 03/15/10

FDA Approves Boston Scientifics Express LD Iliac Stent System
Boston Scientific, 03/12/10

Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron Depot for the Palliative Treatment of Advanced Prostate Cancer
Abbott, 03/12/10

 See all of Drug Approvals

Today in Drug/Product Alerts...keeping you current

Receive free subspecialty "5-minute updates" via email

Watson Announces Actos(R) Patent Challenge Settlement
Watson Pharmaceuticals, 03/11/10

Watson Confirms Filing of Generic Opana(R) ER Application
Watson Pharmaceuticals, 03/09/10

FDA Gives Red Light to Ranbaxy for Generic Flomax
PharmExec, 03/04/10

 See all of Drug/Product Alerts

Today in Pharmacoeconomics...keeping you current

Receive free subspecialty "5-minute updates" via email

Does the Funding Source Influence the Results in Economic Evaluations?: A Case Study in Bisphosphonates for the Treatment of Osteoporosis
PharmacoEconomics, 03/15/10

Cost Effectiveness of Respiratory Syncytial Virus Prophylaxis: A Critical and Systematic Review
PharmacoEconomics, 03/15/10

Pharmacoeconomic Evaluation in Ireland: A Review of the Process
PharmacoEconomics, 03/15/10

 See all of Pharmacoeconomics